Did an interview about Mendus with our analyst @antti.siltanen ! 
Content: 00:00 Intro 00:15 Mendus in a nutshell 00:41 Vididencel in a nutshell 01:35 How does Vididencel differ from available drugs in the market? 02:43 Vididencel phase II trial 04:08 Commercialization of Vididencel 04:45 Frozen products 05:35 Company’s potential in the long run 06:05 Funding 06:48 Role of manufacturing 07:49 Valuation methods 08:43 Valuation for Mendus at the moment